Early Implementation of THAM for ICP Control: Therapeutic Hypothermia Avoidance and Reduction in Hypertonics/Hyperosmotics

Simple item page
dc.contributor.authorZeiler, F. A.
dc.contributor.authorGillman, L. M.
dc.contributor.authorTeitelbaum, J.
dc.contributor.authorWest, M.
dc.date.accessioned2015-05-14T16:08:13Z
dc.date.available2015-05-14T16:08:13Z
dc.date.issued2014-12-4
dc.date.updated2015-03-29T13:26:19Z
dc.description.abstractBackground. Tromethamine (THAM) has been demonstrated to reduce intracranial pressure (ICP). Early consideration for THAM may reduce the need for other measures for ICP control. Objective. To describe 4 cases of early THAM therapy for ICP control and highlight the potential to avoid TH and paralytics and achieve reduction in sedation and hypertonic/hyperosmotic agent requirements. Methods. We reviewed the charts of 4 patients treated with early THAM for ICP control. Results. We identified 2 patients with aneurysmal subarachnoid hemorrhage (SAH) and 2 with traumatic brain injury (TBI) receiving early THAM for ICP control. The mean time to initiation of THAM therapy was 1.8 days, with a mean duration of 5.3 days. In all patients, after 6 to 12 hours of THAM administration, ICP stability was achieved, with reduction in requirements for hypertonic saline and hyperosmotic agents. There was a relative reduction in mean hourly hypertonic saline requirements of 89.1%, 96.1%, 82.4%, and 97.0% for cases 1, 2, 3, and 4, respectively, comparing pre- to post-THAM administration. Mannitol, therapeutic hypothermia, and paralytics were avoided in all patients. Conclusions. Early administration of THAM for ICP control could potentially lead to the avoidance of other ICP directed therapies. Prospective studies of early THAM administration are warranted.
dc.description.versionPeer Reviewed
dc.identifier.citationF. A. Zeiler, L. M. Gillman, J. Teitelbaum, and M. West, “Early Implementation of THAM for ICP Control: Therapeutic Hypothermia Avoidance and Reduction in Hypertonics/Hyperosmotics,” Case Reports in Critical Care, vol. 2014, Article ID 139342, 4 pages, 2014. doi:10.1155/2014/139342
dc.identifier.urihttp://dx.doi.org/10.1155/2014/139342
dc.identifier.urihttp://hdl.handle.net/1993/30471
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2014 F. A. Zeiler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleEarly Implementation of THAM for ICP Control: Therapeutic Hypothermia Avoidance and Reduction in Hypertonics/Hyperosmotics
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
CRICC.2014.139342.xml
Size:
7.92 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
CRICC.2014.139342.pdf
Size:
467.31 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.27 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works